Sophie Paczesny, M.D., Ph.D. (IMAGE)
Caption
A multidisciplinary team led by MUSC Hollings Cancer Center researcher Sophie Paczesny, M.D., Ph.D., developed an AI-based tool that can identify patients at higher risk for serious post-transplant complications before symptoms appear, opening the door to earlier monitoring.
Credit
Medical University of South Carolina
Usage Restrictions
Use with credit to MUSC.
License
Original content